Funding Details
- Awarder
- Inbox
- Date Award
- June 26, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Founding Year
- 2022
- Founders
- Tal Zaks
- Company Description
- Exsilio Therapeutics is a biotechnology startup focused on developing gene-based therapies that can be administered more than once. The company aims to broaden the reach of gene-based drugs in a scalable and efficient way by leveraging mRNA and lipid nanoparticles to insert new DNA into cells' genomes.
- Market
- Genetic Medicine
- Location
-
Boston,
MA,
US
- Coinvestors
- Novartis Venture Fund, Delos Capital, OrbiMed, J.P. Morgan
Links